ProShare Advisors LLC

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1357955 BETHESDA, MD

Position in LCTX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$31,608

+$14,119 QoQ

Shares Held

24,129

-37.9% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#69

of 130 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $337,381,357 across 175 Biotechnology names. LCTX ranks #167 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	287,847	$142,982,240
2	REGN	Regeneron Pharmaceuticals, Inc.	119,240	$74,350,909
3	ALNY	Alnylam Pharmaceuticals, Inc.	128,514	$38,686,569
4	INCY	Incyte Corp	48,152	$5,458,510
5	MRNA	Moderna, Inc.	70,621	$4,945,588
6	CYTK	Cytokinetics Inc	27,121	$2,310,437
7	TECH	BIO-TECHNE Corp	30,597	$2,161,678
8	KRYS	Krystal Biotech, Inc.	4,760	$1,769,149

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$31,608	24,129	-37.9%	Shares	Sole	2026-08-11
2025-03-31	$17,489	38,865	-6.6%	Shares	Sole	2025-05-08
2024-12-31	$20,803	41,606	+49.0%	Shares	Sole	2025-02-14
2024-09-30	$25,402	27,915	+57.1%	Shares	Sole	2024-11-14
2024-06-30	$17,774	17,774	-25.4%	Shares	Sole	2024-08-13
2024-03-31	$35,284	23,841	+8.5%	Shares	Sole	2024-05-08
2023-12-31	$23,940	21,964	+31.0%	Shares	Sole	2024-02-14
2023-09-30	$19,783	16,766	-0.1%	Shares	Sole	2023-11-13
2023-06-30	$23,665	16,784	-28.6%	Shares	Sole	2023-08-10
2022-03-31	$36,210	23,513	-14.2%	Shares	Sole	2022-05-10
2021-12-31	$67,122	27,397	+70.5%	Shares	Sole	2022-02-08
2021-09-30	$40,498	16,071	-48.9%	Shares	Sole	2021-11-12
2021-06-30	$89,658	31,459	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.